A retrospective descriptive cross-sectional study of Oral Dosage Form Administered in The Form of Suspension to ICU Patients at Hospital X

Nelly Suryani, Vidia Arliani Anwar, Yardi Saibi, Estu Mahanani Dhilasari, Sabrina Dahlizar, Ofa Suzanti Betha, Afifah Nurnishrina Azzahra

Abstract


Patients in the intensive care unit were often very sick and had lost consciousness. Because they had trouble swallowing, individuals with reduced awareness frequently depended on enteral tubes (NGT) for their daily medical and nutritional requirements. Since not all medications were accessible in parenteral forms, patients who relied on enteral tubes often had issues, including drug stability. Many problems arose in clinical usage when the medication was crushed or suspended and put into the NGT, including drug obstruction in the enteral tube and a reduction in drug stability as a result of the dose form being altered, making the drug unstable. Thus, this study aimed to ascertain the stability of oral suspension medications given to intensive care unit patients. The medical records of intensive care unit patients who had received oral medication therapy at X Hospital in Jakarta were examined retrospectively using a cross-sectional, descriptive approach. According to the statistics, coated tablets accounted for 68% of the most frequently used oral medication preparations. It was highly likely that crushing the coated tablets and administering them via NGT had resulted in tube obstruction. Additionally, 59.26% of the medications used had exhibited hygroscopic qualities, and several had been readily hydrolyzed. Based on these findings, it was concluded that oral medications, particularly crushed-coated tablets, could negatively affect drug stability. Active substances with hygroscopic properties and those prone to hydrolysis were also identified as potential contributors to instability.


Keywords


ICU, Stability, Enteral Tube, Oral Medicine, Hygroscopic, Hydrolysis

References


Allada, R., et al. (2016) ‘Hygroscopicity Categorization of Pharmaceutical Solids by Gravimetric Sorption Analysis: A Systemitic Approach’, Asian Journal of Pharmaceutics, p. 279.

Allwood, M.C., & K.M.C.J. (1998) Compatibility and Stability of Additives in Parenteral Nutrition Admixtures. 9th edn.

Ananta, T.B. and Fitri, A.L.D. (2020) ‘Mobilisasi Dini Pada Pasien Kritis Di Intensive Care Unit (Icu)’, Case Study. J Keperawatan Widya Gantari Indones, 4(1), pp. 59–66.

Banker GS and Rhodes CT (2011) ‘Karakteristik Pasien Usia Lanjut di Ruang Rawat Intensif Rumah Sakit Immanuel Bandung’, JKM, 10(2), pp. 110–119.

Basusarkar, A., Kandimalla, A., Dudley, R., et al. (2013) ‘Chemical Stability of Compounded Spironolactone Suspension in Proprietary Oral Mix’, J.Pharm Sci, 23(1), pp. 67–70.

Bernardus, R., and Kurniawan (2013) ‘Stabilitas Resep Racikan yang Berpotensi Mengalami Inkompatibilitas Farmasetika yangg Disimpan pada Wadah Tertutup Baik’, Jurnal Ilmiah Mahasiswa Universitas Surabaya, 2(2).

Gayatricitraningtyas and Abidjulu, J. (2012) ‘Pengaruh Suhu Terhadap Stabilitas Serta Penetapan Kadar Tablet Furosemida Menggunakan Spektrofotometer Uv-Vis’, Pharmacon, 1(2), pp. 93–97.

Gupta, A.K., et al. (2018) ‘Update on Current Approaches to Diagnosis and Treatment of Onychomycosis’, Pubmed, pp. 929–938.

Hanifah, S. (2015) ‘Identifikasi pH Obat-Obat yang Digunakan di Pediatric Intensive Care Unit (PICU) untuk Pencegahan Inkompatibiltas Intravena’, Ilm Farm, 11(2), pp. 55–64.

Kunieda, K., et al. (2021) ‘A Safe Way to Administer Drugs Through a Nutrition Tube—The Simple Suspension Method’, Dysphhagia, 37(2), pp. 318–322.

Li, Z., et al. (2019) ‘Role of Esterase Mediated Hydrolysis of Simvastatin in uman and Rat Blood and Its Impact on Pharmacokinetic Profiles of Simvastatin and Its Active Metabolite in Rat’, J Pharm Biomed Anal, 168, pp. 13–22.

Madden, A. (2007) Handbook of Drug Administration Via Enteral Feeding Tubes. 2nd edn.

Rahmawati, R., et al. (2018) ‘Problem Kompatibilitas dan Stabilitas Pencampuran Sediaan Intravena Pada Pasien Anak di RSUP Dr. Sardjito’, Intravenous Drug Compatibility and Stability Problem in Pediatric Patient at RSUP Dr. Sardjito, p. 7.

Remington, J.P. (2021) Remington - The Science and Practice of Pharmacy. 21st ed.

Root, T., et al. (2011) ‘Pharmaceutical Issues when Crushing , Opening or Splitting Oral Dosage Forms’, R Pharm Soc, 1, pp. 1–7.

Sigmon, D.F., and An, J. (2021) ‘Nasogastric Tube’, Petunjuk Teknis Penyelenggaraan Pelayanan Intensive Care Unit di Rumah Sakit , p. 53.

Sinaga, E. (2013) Strategi Meningkatkan Penghantaran Obat Di Dalam Tubuh. Edited by UNAS Press.

Thong, M.Y., Manrique, Y.J., & and Steadman, K.J. (2018) ‘Drug Loss While Crushing Tablets: Comparison of 24 Tablet Crushing Devices’, PLoS ONE, 13.

Valentovic, M. (2007) ‘Simvastatin’, xPharm Compr Pharmacol Ref, 1, pp. 1–4.


Full Text: PDF

DOI: 10.15408/pbsj.v6i2.41341

Refbacks

  • There are currently no refbacks.